• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻家族性高胆固醇血症患者颈动脉粥样硬化斑块评估。

The Assessment of Carotid Atherosclerotic Plaque among Young Patients with Familial Hypercholesterolemia.

机构信息

Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Japan.

出版信息

Intern Med. 2022;61(21):3165-3169. doi: 10.2169/internalmedicine.9249-21. Epub 2022 Nov 1.

DOI:10.2169/internalmedicine.9249-21
PMID:36328583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9683824/
Abstract

Objective Few data exist regarding when atherosclerotic changes occur among patients with familial hypercholesterolemia (FH). Carotid ultrasonography is a non-invasive method of evaluating this issue. The present study (1) compared the clinical utilities of carotid intima-media thickness (cIMT) and carotid plaque score (cPS) and (2) estimated the onset and progression of carotid atherosclerosis among patients with heterozygous FH (HeFH). Methods We retrospectively analyzed 511 patients under 30 years old who underwent carotid ultrasonography at our hospital from 2006 to 2019. We classified them into the HeFH group (n=78, 21.4±5.9 years old) and non-FH group (n=433, 23.4±6.0 years old) based on the clinical diagnosis and compared their cIMT and cPS values. In addition, we estimated the onset and progression of carotid atherosclerosis among young HeFH patients. Results There was no significant difference in the cIMT between the HeFH and non-FH groups (0.44 mm vs. 0.42 mm, p=0.25). In contrast, the cPS was significantly higher in the HeFH group than in the non-FH group (1.11 vs. 0.26, p=0.002). The regression equation for cPS of HeFH group was Y=-2.05+0.15X (r=0.37, p<0.001). Conclusion An assessment based on the cPS rather than the cIMT appears to be better to capture the progress of carotid atherosclerosis among young HeFH patients. Carotid atherosclerosis may start to develop at 14 years old in patients with HeFH.

摘要

目的

家族性高胆固醇血症(FH)患者的动脉粥样硬化变化发生时间的数据较少。颈动脉超声是评估此问题的一种非侵入性方法。本研究(1)比较了颈动脉内膜中层厚度(cIMT)和颈动脉斑块评分(cPS)的临床效用,(2)估计了杂合子 FH(HeFH)患者颈动脉粥样硬化的发病和进展情况。

方法

我们回顾性分析了 2006 年至 2019 年在我院接受颈动脉超声检查的 511 名年龄在 30 岁以下的患者。根据临床诊断将他们分为 HeFH 组(n=78,21.4±5.9 岁)和非 FH 组(n=433,23.4±6.0 岁),并比较了他们的 cIMT 和 cPS 值。此外,我们还估计了年轻 HeFH 患者颈动脉粥样硬化的发病和进展情况。

结果

HeFH 组和非 FH 组之间 cIMT 无显著差异(0.44mm vs. 0.42mm,p=0.25)。相比之下,HeFH 组的 cPS 明显高于非 FH 组(1.11 vs. 0.26,p=0.002)。HeFH 组 cPS 的回归方程为 Y=-2.05+0.15X(r=0.37,p<0.001)。

结论

基于 cPS 的评估似乎比 cIMT 更能捕捉年轻 HeFH 患者颈动脉粥样硬化的进展。HeFH 患者的颈动脉粥样硬化可能在 14 岁时开始发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a0e/9683824/c534fecd85b9/1349-7235-61-3165-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a0e/9683824/a8e9a414abb5/1349-7235-61-3165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a0e/9683824/66e21fc82b7e/1349-7235-61-3165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a0e/9683824/c534fecd85b9/1349-7235-61-3165-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a0e/9683824/a8e9a414abb5/1349-7235-61-3165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a0e/9683824/66e21fc82b7e/1349-7235-61-3165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a0e/9683824/c534fecd85b9/1349-7235-61-3165-g003.jpg

相似文献

1
The Assessment of Carotid Atherosclerotic Plaque among Young Patients with Familial Hypercholesterolemia.年轻家族性高胆固醇血症患者颈动脉粥样硬化斑块评估。
Intern Med. 2022;61(21):3165-3169. doi: 10.2169/internalmedicine.9249-21. Epub 2022 Nov 1.
2
Assessments of Carotid Artery Plaque Burden in Patients With Familial Hypercholesterolemia.家族性高胆固醇血症患者颈动脉斑块负荷的评估
Am J Cardiol. 2017 Dec 1;120(11):1955-1960. doi: 10.1016/j.amjcard.2017.08.012. Epub 2017 Aug 30.
3
Assessment of subclinical atherosclerosis and intraplaque neovascularization using quantitative contrast-enhanced ultrasound in patients with familial hypercholesterolemia.应用定量对比增强超声评估家族性高胆固醇血症患者的亚临床动脉粥样硬化及斑块内新生血管。
Atherosclerosis. 2013 Nov;231(1):107-13. doi: 10.1016/j.atherosclerosis.2013.08.040. Epub 2013 Sep 11.
4
Detection of subclinical atherosclerosis in familial hypercholesterolemia using non-invasive imaging modalities.采用非侵入性影像学方法检测家族性高胆固醇血症的亚临床动脉粥样硬化。
Atherosclerosis. 2012 Jun;222(2):468-72. doi: 10.1016/j.atherosclerosis.2012.02.043. Epub 2012 Mar 7.
5
Lipoprotein(a) level associates with coronary artery disease rather than carotid lesions in patients with familial hypercholesterolemia.在家族性高胆固醇血症患者中,脂蛋白(a)水平与冠状动脉疾病相关,而非与颈动脉病变相关。
J Clin Lab Anal. 2018 Sep;32(7):e22442. doi: 10.1002/jcla.22442. Epub 2018 Mar 30.
6
Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study.长期接受他汀类药物治疗的家族性高胆固醇血症患者的颈动脉斑块和内膜中层厚度:一项病例对照研究。
Atherosclerosis. 2017 Jan;256:62-66. doi: 10.1016/j.atherosclerosis.2016.12.005. Epub 2016 Dec 2.
7
Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label).阿托伐他汀对杂合子家族性高胆固醇血症患儿颈动脉内膜中层厚度的影响:CHARON 研究(儿童和青少年服用阿托伐他汀开放性标签研究中的高胆固醇血症)。
Circulation. 2017 Jul 25;136(4):359-366. doi: 10.1161/CIRCULATIONAHA.116.025158. Epub 2017 Jun 7.
8
Endothelial dysfunction, but not structural atherosclerosis, is evident early in children with heterozygous familial hypercholesterolemia.在杂合子家族性高胆固醇血症患儿中,早期即可出现内皮功能障碍,但无结构性动脉粥样硬化。
Pediatr Cardiol. 2014 Jan;35(1):63-70. doi: 10.1007/s00246-013-0742-0. Epub 2013 Jul 3.
9
Carotid intima-media thickness in children with familial hypercholesterolemia.家族性高胆固醇血症患儿的颈动脉内膜中层厚度。
Circ Res. 2014 Jan 17;114(2):307-10. doi: 10.1161/CIRCRESAHA.114.301430. Epub 2013 Nov 5.
10
The different relations of PCSK9 and Lp(a) to the presence and severity of atherosclerotic lesions in patients with familial hypercholesterolemia.载脂蛋白(a)和前蛋白转化酶枯草溶菌素 9 与家族性高胆固醇血症患者动脉粥样硬化病变的存在及严重程度的关系。
Atherosclerosis. 2018 Oct;277:7-14. doi: 10.1016/j.atherosclerosis.2018.07.030. Epub 2018 Jul 26.

引用本文的文献

1
Early Atherosclerosis in Familial Hypercholesterolemia Patients: Significance of Vascular Markers for Risk Stratification.家族性高胆固醇血症患者的早期动脉粥样硬化:血管标志物在风险分层中的意义
J Cardiovasc Dev Dis. 2024 Mar 13;11(3):91. doi: 10.3390/jcdd11030091.

本文引用的文献

1
Effect of Cumulative Exposure to Low-Density Lipoprotein-Cholesterol on Cardiovascular Events in Patients With Familial Hypercholesterolemia.家族性高胆固醇血症患者 LDL-胆固醇累积暴露对心血管事件的影响。
Circ J. 2021 Oct 25;85(11):2073-2078. doi: 10.1253/circj.CJ-21-0193. Epub 2021 May 20.
2
Homozygous Familial Hypercholesterolemia.纯合子家族性高胆固醇血症。
J Atheroscler Thromb. 2021 Jul 1;28(7):665-678. doi: 10.5551/jat.RV17050. Epub 2021 Apr 18.
3
Familial Hypercholesterolemia: A Narrative Review on Diagnosis and Management Strategies for Children and Adolescents.
家族性高胆固醇血症:儿童和青少年的诊断与管理策略述评。
Vasc Health Risk Manag. 2021 Feb 17;17:59-67. doi: 10.2147/VHRM.S266249. eCollection 2021.
4
Prognostic impact of cascade screening for familial hypercholesterolemia on cardiovascular events.家族性高胆固醇血症级联筛查对心血管事件的预后影响。
J Clin Lipidol. 2021 Mar-Apr;15(2):358-365. doi: 10.1016/j.jacl.2020.12.012. Epub 2021 Jan 4.
5
Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study.家族性高胆固醇血症患者的冠状动脉斑块负担、斑块特征及其预后意义:一项 CT 血管造影研究。
Atherosclerosis. 2021 Jan;317:52-58. doi: 10.1016/j.atherosclerosis.2020.11.012. Epub 2020 Nov 18.
6
Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.全球家族性高胆固醇血症患病率的Meta 分析:1100 万例患者研究
J Am Coll Cardiol. 2020 May 26;75(20):2553-2566. doi: 10.1016/j.jacc.2020.03.057.
7
A catalog of the pathogenic mutations of LDL receptor gene in Japanese familial hypercholesterolemia.日本家族性高胆固醇血症中低密度脂蛋白受体基因的致病突变目录。
J Clin Lipidol. 2020 May-Jun;14(3):346-351.e9. doi: 10.1016/j.jacl.2020.03.002. Epub 2020 Mar 24.
8
20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia.20 年随访家族性高胆固醇血症患儿他汀类药物治疗。
N Engl J Med. 2019 Oct 17;381(16):1547-1556. doi: 10.1056/NEJMoa1816454.
9
Clinical Impact of Carotid Plaque Score rather than Carotid Intima-Media Thickness on Recurrence of Atherosclerotic Cardiovascular Disease Events.颈动脉斑块评分而非颈动脉内中膜厚度对动脉粥样硬化性心血管疾病事件复发的临床影响。
J Atheroscler Thromb. 2020 Jan 1;27(1):38-46. doi: 10.5551/jat.49551. Epub 2019 May 18.
10
Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy.家族性高胆固醇血症患者接受标准降脂治疗后的冠状动脉钙和心血管事件。
JACC Cardiovasc Imaging. 2019 Sep;12(9):1797-1804. doi: 10.1016/j.jcmg.2018.09.019. Epub 2018 Nov 15.